Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 19, Issue 2, 2009, Pages 155-166

  Ghuman, Jaswinder K ^a,d   Aman, Michael G ^b   Ghuman, Harinder S ^a   Reichenbacher, Thomas ^a   Gelenberg, Alan ^a,c   Wright, Ron ^a   Rice, Sydney ^a   Fort, Carolyn ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Healthcare Technology Systems Inc   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE;

AGGRESSION; ANGER; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; BEDTIME DOSAGE; BEHAVIOR DISORDER; CARDIOVASCULAR PARAMETERS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED STUDY; DECREASED APPETITE; DIARRHEA; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL DISEASE; HEADACHE; HEIGHT; HUMAN; IRRITABILITY; MALE; MORNING DOSAGE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PSYCHOSOCIAL WITHDRAWAL; RATING SCALE; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; THIRST; THORAX PAIN; TIC; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT;

ADRENERGIC UPTAKE INHIBITORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PILOT PROJECTS; PROPYLAMINES; PROSPECTIVE STUDIES; PSYCHOLOGICAL TESTS;

EID: 65249142203     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2008.054     Document Type: Article

References (68)

1. Adler LA, Spencer TJ, Milton DR, Moore RJ, Michelson D: Longterm, open-label study of the safety and efficacy of atomox- etine in adults with attention-deficit/hyperactivity disorder: An interim analysis. J Clin Psychiatry 66: 294-299, 2005.
2. Allen A, Michelson D, Kelsey DK, Heiligenstein JH, Faries DE, Sumner CR, Thomason CK: Once or twice-daily atomoxetine treatment in children and adolescents with ADHD - Does it make a difference? Biolog Psychiatry 53:206S-206S, 2003.
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Text Revision (DSM-IV-TR). Washington (DC): American Psychiatric Association; 2000.
4. Arnold LE, Vitiello B, McDougle C, Scahill L, Shah B, Gonzalez NM, Chuang S, Davies M, Holloway J, Aman MG, Cronin P, Koenig K, Kohn AE, McMahon DJ, Tierney E: Parent-defined target symptoms respond to risperidone in RUPP Autism Study: Customer approach to clinical trials. J Am Acad Child Adolesc Psychiatry 42:1443-1450, 2003.
5. Bangs ME, Emslie GJ, Spencer TJ, Ramsey JL, Carlson C, Bartky EJ, Busner J, Duesenberg DA, HarshawatP,Kaplan SL, Quintana H, Allen AJ, Sumner CR: Efficacy and safety of atomoxetine in adolescents with attention-deficit/ hyperactivity disorder and major depression. J Child Adolesc Psychopharmacol 17:407-420, 2007.
6. Beck MH, Cataldo M, Slifer KJ, Pulbrook V, Guhman JK: Teaching children with attention deficit hyperactivity disorder (ADHD) and autistic disorder (AD) how to swallow pills. Clin Pediatr 44:515, 2005.
7. Biederman J, Spencer TJ: Psychopharmacological interventions. Child Adolesc Psychiatr Clin N Am 17:439-458, xi, 2008.
8. Biederman J, Heiligenstein JH, Faries DE, Galil N, Dittmann R, Emslie GJ, Kratochvil CJ, Laws HF, Schuh KJ: Efficacy of atomoxetine versus placebo in school-age girls with attentiondeficit/hyperactivity disorder. Pediatrics 110:e75; 2002.
9. Biederman J, Arnsten AF, Faraone SV, Doyle AE, Spencer TJ, Wilens TE, Weiss MD, Safren SA, Culpepper L: New developments in the treatment of ADHD. J Clin Psychiatry 67:148-159, 2006a.
10. Biederman J, Monuteaux MC, Mick E, Spencer T, Wilens TE, Silva JM, Snyder LE, Faraone SV: Young adult outcome of attention deficit hyperactivity disorder: A controlled 10-year follow-up study. Psychol Med 36:167-179, 2006b.
11. Bird HR, Yager TJ, Staghezza B, Gould MS, Canino G, RubioStipec M: Impairment in the epidemiological measurement of childhood psychopathology in the community. J Am Acad Child Adolesc Psychiatry 29:796-803, 1990.
12. Birnbaum HG, Kessler RC, Lowe SW, Secnik K, Greenberg PE, Leong SA, Swensen AR: Costs of attention deficit-hyperactivity disorder (ADHD) in the US: Excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin 21:195-206, 2005.
13. Campbell SB, Ewing LJ: Follow-up of hard-to-manage preschoolers: Adjustment at age 9 and predictors of continuing symptoms. J Child Psychol Psychiatry 31:871-889, 1990.
14. Campbell SB, Shaw DS, Gilliom M: Early externalizing behavior problems: Toddlers and preschoolers at risk for later maladjustment. Dev Psychopathol 12:467-488, 2000.
15. Cohen-Zion M, Ancoli-Israel S: Sleep in children with attention-deficit hyperactivity disorder (ADHD): A review of naturalistic and stimulant intervention studies. Sleep Med Rev 8:379-402, 2004.
16. Connor DF: Preschool attention deficit hyperactivity disorder: A review of prevalence, diagnosis, neurobiology, and stimulant treatment. J Dev Behav Pediatr 23:S1-S9, 2002.
17. Dulcan MK, Benson RS: AACAP Official Action. Summary of the practice parameters for the assessment and treatment of children, adolescents, and adults with ADHD. J Am Acad Child Adolesc Psychiatry 36:1311-1317, 1997.
18. Dunlap WP, Cortina JM, Vaslow JB, Burke MJ: Meta-analysis of experiments with matched groups or repeated measures designs. Psycholog Methods 1:170-177, 1996.
19. Egeland B, Kalkoske M, Gottesman N, Erickson MF: Preschool behavior problems: Stability and factors accounting for change. J Child Psychol Psychiatry 31:891-909, 1990.
20. Egger HL, Angold A: Common emotional and behavioral disorders in preschool children: Presentation, nosology, and epidemiology. J Child Psychol Psychiatry Allied Discipl 47: 313-237, 2006.
21. Gadow KD, Sprafkin J, Nolan EE: DSM-IV symptoms in community and clinic preschool children. J Am Acad Child Adolesc Psychiatry 40:1383-1392, 2001.
22. Geller D, Donnelly C, Lopez F, Rubin R, Newcorn J, Sutton V, Bakken R, Paczkowski M, Kelsey D, Sumner C: Atomoxetine treatment for pediatric patients with attention-deficit/ hyperactivity disorder with comorbid anxiety disorder. J Am Acad Child Adolesc Psychiatry 46:1119-1127, 2007.
23. Ghuman JK, Ginsburg GS, Subramaniam G, Ghuman HS, Kau AS, Riddle MA: Psychostimulants in preschool children with attention-deficit/hyperactivity disorder: Clinical evidence from a developmental disorders institution. J Am Acad Child Adolesc Psychiatry 40:516-524, 2001.
24. Ghuman JK, Cataldo MD, Beck MH, Slifer KJ: Behavioral training for pill-swallowing difficulties in young children with autistic disorder. J Child Adolesc Psychopharmacol 14:601-611, 2004.
25. Ghuman JK, Riddle MA, Vitiello B, Greenhill LL, Chuang SZ, Wigal SB, Kollins SH, Abikoff HB, McCracken JT, Kastelic E: Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol 17:563-580, 2007.
26. Greenhill LL, Vitiello B, Riddle MA, Fisher P, Shockey E, March JS, Levine J, Fried J, Abikoff H, Zito JM, McCracken JT, Findling RL, Robinson J, Cooper TB, Davies M, Varipatis E, Labellarte MJ, Scahill L, Walkup JT, Capasso L, Rosengarten J: Review of safety assessment methods used in pediatric psy-chopharmacology. J Am Acad Child Adolesc Psychiatry 42:627-633, 2003.
27. Greenhill L, Kollins S, Abikoff H, McCracken J, Riddle M, Swanson J, McGough J, Wigal S, Wigal T, Vitiello B, Skrobala A, Posner K, Ghuman J, Cunningham C, Davies M, Chuang S, Cooper T: Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 45:1284-1293, 2006.
28. Guy W: ECDEU Assessment Manual for Psychopharmacology (Revised). Washington (DC): Department of Health Education and Welfare, 1976.
29. Heiligenstein JH, Michelson D: Atomoxetine - a selective and specific noradrenergic uptake inhibitor for the treatment of pediatric and adult attention-deficit/hyperactivity disorder. Nordic J Psychiatry 57:91-91, 2003.
30. Higgins ES: A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder. J Fam Pract 48:15-20, 1999.
31. Hollingshead AB: Four factor index of social status. Unpublished manuscript, New Haven, (Connecticut): Yale University, 1975.
32. Hoza B: Peer functioning in children with ADHD. J Pediatr Psychol 32:655-663, 2007.
33. Keenan K, Shaw DS, Walsh B, Delliquadri E, Giovannelli J: DSM-III-R disorders in preschool children from low-income families. J Am Acad Child Adolesc Psychiatry 36:620-627, 1997.
34. Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ: Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial. Pediatrics 114:e1-e8, 2004.
35. Kessler RC, Adler LA, Barkley R, Biederman J, Conners CK, Faraone SV, Greenhill LL, Jaeger S, Secnik K, Spencer T, Ustun TB, Zaslavsky AM: Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: Results from the national comorbidity survey replication. Biol Psychiatry 57:1442-1451, 2005.
36. Kratochvil CJ, Vaughan BS, Mayfield-Jorgensen ML, March JS, Kollins SH, Murray DW, Ravi H, Greenhill LL, Kotler LA, Paykina N, Biggins P, Stoner J: A pilot study of atomoxetine in young children with attention-deficit/ hyperactivity disorder. J Child Adolesc Psychopharmacol 17:175-185, 2007.
37. Lavigne JV, Gibbons RD, Christoffel KK, Kaufer K, Arend R, Rosenbaum D, Binns H, Dawson N, Sobel H, Isaacs C: Prevalence rates and correlates of psychiatric disorders among preschool children. J Am Acad Child Adolesc Psychiatry 35:204-214, 1996.
38. Lee SS, Lahey BB, Owens EB, Hinshaw SP: Few preschool boys and girls with ADHD are well-adjusted during adolescence. J Abnorm Child Psychol 36:373-83, 2008.
39. Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, Newcorn J, Sallee FR, Sangal RB, Saylor K: Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized, placebocontrolled study. Am J Psychiatry 159:1896, 2002.
40. Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR, Spencer T, Atomoxetine A: Atomoxetine in the treatment of children and adolescents with attention-deficit. Pediatrics 108:E83, 2001.
41. Molina BS, Flory K, Hinshaw SP, Greiner AR, Arnold LE, Swanson JM, Hechtman L, Jensen PS, Vitiello B, Hoza B, Pelham WE, Elliott GR, Wells KC, Abikoff HB, Gibbons RD, Marcus S, Conners CK, Epstein JN, Greenhill LL, March JS, Newcorn JH, Severe JB, Wigal T: Delinquent behavior and emerging substance use in the MTA at 36 months: Prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry 46:1028-1040, 2007.
42. Newcorn JH, Spencer TJ, Biederman J, Milton DR, Michelson D: Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppo-sitional defiant disorder. J Am Acad Child Adolesc Psychiatry 44:240-248, 2005.
43. National Institute of Mental Health: Special feature: Rating scales and assessment instruments for use in pediatric psychophar-macology research. Psychopharmacol Bull 12:1077-1080, 1985.
44. Pelham WE, Chacko A, Wymbs BT: Diagnostic and assessment issues of attention deficit/hyperactivity disorder in the young child. In: Handbook of Infant, Toddler, and Preschool Mental Health Assessment. Eds: Delcarmen-Wiggins R, Carter A. New York: Oxford University Press, 2004. pp 399-420.
45. Posner K, Melvin GA, Murray DW, Gugga SS, Fisher P, Skrobala A, Cunningham C, Vitiello B, Abikoff HB, Ghuman JK, Kollins S, Wigal SB, Wigal T, McCracken JT, McGough JJ, Kastelic E, Boorady R, Davies M, Chuang SZ, Swanson JM, Riddle MA, Greenhill LL: Clinical presentation of attention-deficit/ hyper activity disorder in preschool children: The Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol 17:547-562, 2007.
46. Rappley MD, Mullan PB, Alvarez FJ, Eneli IU, Wang J, Gardiner JC: Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children. Arch Pediatr Adolesc Med 153:1039-1045, 1999.
47. Rappley MD, Eneli IU, Mullan PB, Alvarez FJ, Wang J, Luo Z, Gardiner JC: Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder. J Dev Behav Pediatr 23:23-30, 2002.
48. Richman N, Stevenson J, Graham P: Pre-school to School: A Behavioural Study. London: Academic Press, 1982.
49. Rosenthal R, Rosnow RL, Rubin DB: Contrasts and Effect Sizes in Behavioral Research: A Correlational Approach. Cambridge: Cambridge University Press, 2000.
50. Safer DJ, Zito JM: Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: Children versus adolescents. J Child Adolesc Psychopharmacol 16:159-169, 2006.
51. Shaffer D, Gould M, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwalia S: A children's global assessment scale (C-GAS). Arch GenPsychiatry 40:1228-1231, 1983.
52. Silver LB: Alternative (nonstimulant) medications in the treatment of attention-deficit/hyperactivity disorder in children. Pediatr Clin N Am 46:965-975, 1999.
53. Spencer T, Heiligenstein JH, Biederman J, Faries DE, Kratochvil CJ, Conners CK, Potter WZ: Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry 63:1140-1147, 2002.
54. Sprafkin J, Volpe RJ, Gadow KD, Nolan EE, Kelly K: A DSM-IV-referenced screening instrument for preschool children: The Early Childhood Inventory-4. J Am Acad Child Adolesc Psychiatry 41:604-612, 2002.
55. Swanson J, Greenhill L, Wigal T, Kollins S, Stehli A, Davies M, Chuang S, Vitiello B, Skrobala A, Posner K, Abikoff H, Oatis M, McCracken J, McGough J, Riddle M, Ghuman J, Cunningham C, Wigal S: Stimulant-related reductions of growth rates in the PATS. J Am Acad Child Adolesc Psychiatry 45:1304-1313, 2006.
56. Swanson JM: School-Based Assessments and Interventions for ADD Students. Irvine (California): KC Publishing, 1992.
57. Van Brunt DL, Johnston JA, Ye WY, Pohl GM, Sun PJ, Sterling KL, Davis ME: Predictors of selecting atomoxetine therapy for children with attention-deficit-hyperactivity disorder. Phar-macotherapy 25:1541-1549, 2005.
58. Weissman MM, Warner V, Fendrich M: Applying impairment criteria to children's psychiatric diagnosis. J Am Acad Child Adolesc Psychiatry 29:789-795, 1990.
59. Wigal T, Greenhill L, Chuang S, McGough J, Vitiello B, Skrobala A, Swanson J, Wigal S, Abikoff H, Kollins S, McCracken J, Riddle M, Posner K, Ghuman J, Davies M, Thorp B, Stehli A: Safety and tolerability of methylphenidate in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry 45: 1294-1303, 2006.
60. Wilens TE: A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 158: 282-288, 2001.
61. Wilens TE: Mechanism of action of agents used in attention-deficit/ hyperactivity disorder. J Clin Psychiatry 67(Suppl 8): 32-38, 2006.
62. Wilens TE: The nature of the relationship between attention-deficit/ hyperactivity disorder and substance use. J Clin Psychiatry 68(Suppl 11):4-8, 2007.
63. WilensTE, BiedermanJ,BrownS,MonuteauxM,PrinceJ,Spencer TJ: Patterns of psychopathology and dysfunction in clinically referred preschoolers. J Dev Behav Pediatr 23:S31-S36, 2002a.
64. Wilens TE, Biederman J, Spencer TJ: Attention deficit/ hyperactivity disorder across the lifespan. Ann Rev Med 53: 113-131, 2002b.
65. Wilens TE, Kratochvil C, Newcorn JH, Gao H: Do children and adolescents with ADHD respond differently to atomoxetine? J Am Acad Child Adolesc Psychiatry 45:149-157, 2006a.
66. Wilens TE, Newcorn JH, Kratochvil CJ, Gao H, Thomason CK, Rogers AK, Feldman PD, Levine LR: Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder. J Pediatr 149:112-119, 2006b.
67. Zito JM, Safer DJ, Valluri S: Psychotherapeutic medication prevalence in Medicaid-insured preschoolers. J Child AdolescPsychopharmacol 17:195, 2007.
68. Zuckerman ML, Vaughan BL, Whitney J, Dodds A, Yakhkind A, MacMillan C, Raches D, Pravdova I, DeMaso DR, Beardslee WR, Gonzalez-Heydrich J: Tolerability of selective serotonin reuptake inhibitors in thirty-nine children under age seven: A retrospective chart review. J Child Adolesc Psychopharmacol 17:165-174, 2007.